European Patent Office

T 1317/13 (anti-IL-1beta therapy/NOVARTIS) of 09.02.2018

European Case Law Identifier
ECLI:EP:BA:2018:T131713.20180209
Date of decision
9 February 2018
Case number
T 1317/13
Petition for review of
-
Application number
08760116.7
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
New indications for anti-IL-I-beta therapy
Applicant name
Novartis AG
Opponent name
-
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 56
Keywords
Inventive step - (no)
Catchword
-
Cited cases
T 0021/81

Order

For these reasons it is decided that:

The appeal is dismissed.